Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Fenspiride hydrochloride
Cat. No.:
OB0225LY-0173
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Fenspiride hydrochloride is a medication used to relieve the symptoms of respiratory diseases and has anti-inflammatory properties.
Synonym:
Fenspiride HCl; Pneumorel; Fluiden; Decaspiride; 5053-08-7; 8-(2-Phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one hydrochloride
CAS No.:
5053-08-7
Compound CID:
68626
Formula:
C15H20N2O2·HCl
Formula Weight:
296.79
Specification
Relative Density:
1.19 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Fenspiride hydrochloride can be used for respiratory inflammation and asthma research.
Library Information
Targets:
Histamine receptor; PDE family; Adrenergic receptor
Receptors:
H1 receptor; PDE3; PDE4
Pathways:
GPCR/G protein; Neuronal signaling; Metabolism; Immunology/Inflammation
Plate Number:
AOCL-3
Plate Location:
b6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
9 mg/mL; 30.32 mM
Water Max Solubility:
54 mg/mL; 181.9 mM
Ethanol Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
